A covalently stabilized lipid-polycation-DNA (sLPD) vector for antisense oligonucleotide delivery.
A covalently stabilized lipid-polycation-DNA (sLPD) vector for antisense oligonucleotide delivery.
复制标题
用于反义寡核苷酸递送的共价稳定脂质聚阳离子 DNA (sLPD) 载体。
DOI:
10.1021/mp100272k
复制
发表时间:
2011
影响因子:
4.9
通讯作者:
Lee,RobertJ
中科院分区:
文献类型:
--
作者:
Yang,Xiaojuan;Peng,Yong;Yu,Bo;Yu,Jianhua;Zhou,Chenguang;Mao,Yicheng;Lee,LJames;Lee,RobertJ
Antisense oligonucleotide G3139 is designed for Bcl-2 downregulation and is known to induce toll-like receptor activation. Novel stabilized lipid−polycation−DNA (sLPD) nanoparticles were constructed and evaluated for the delivery of G3139 to human carcinoma KB cells and for bioactivityin vivo. Polyethylenimine (PEI) was incorporated as a DNA condensing agent. The lipid composition used was DOTAP/DDAB/Chol/TPGS/linoleic acid/hexadecenal at molar ratios of 30/30/34/1/5/0.2. The nanoparticles were stabilized by the formation of a reversible covalent bond between the aldehyde group on thecis-11-hexadecenal and amines on the PEI. When sLPDs were used to transfect KB cells, 90.4% Bcl-2 downregulation was observed, compared to no significant downregulation by free G3139 and 54.6% downregulation by nonstabilized LPD-G3139. The sLPDs were then evaluated for therapeutic efficacy in mice bearing KB subcutaneous tumors and were found to trigger a strong antitumor response, inhibiting tumor growth and prolonging survival with 72% increase in lifespan (ILS). Consistent with previous reports on other G3139 nanoparticles, the increased antitumor activities of sLPDs in vivo were found to be associated with increased cytokine induction rather than Bcl-2 downregulation, suggesting an immunological mechanism.